Clincosm LogoSign in Get a demo

Multiple Myeloma

Showing NaN - NaN of 77
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Multiple Myeloma Trial in Worldwide (idecabtagene vicleucel, Lenalidomide, Fludarabine)

Not yet recruiting
  • Multiple Myeloma
  • idecabtagene vicleucel
  • +3 more
  • Gilbert, Arizona
  • +107 more
Sep 26, 2023

Multiple Myeloma Trial in Worldwide (Iberdomide, Lenalidomide)

Not yet recruiting
  • Multiple Myeloma
  • Orange, California
  • +270 more
Apr 11, 2023

Multiple Myeloma Trial in Worldwide (Bortezomib, Dexamethasone, Lenalidomide)

Recruiting
  • Multiple Myeloma
  • San Francisco, California
  • +152 more
Jan 27, 2023

Multiple Myeloma Trial in Worldwide (Elranatamab, Lenalidomide)

Recruiting
  • Multiple Myeloma
  • Benowa, Queensland, Australia
  • +132 more
Jan 24, 2023

Multiple Myeloma Trial in Worldwide (Selinexor, Dexamethasone)

Completed
Has Results
  • Multiple Myeloma
  • Birmingham, Alabama
  • +60 more
Jan 24, 2023

Multiple Myeloma Trial in Worldwide (JNJ-68284528, Pomalidomide, Bortezomib)

Active, not recruiting
  • Multiple Myeloma
  • Birmingham, Alabama
  • +87 more
Jan 17, 2023

Multiple Myeloma Trial in Worldwide (Daratumumab, Pomalidomide, Dexamethasone)

Recruiting
  • Multiple Myeloma
  • Birmingham, Alabama
  • +198 more
Jan 17, 2023

Multiple Myeloma Trial in Worldwide (Placebo, Ixazomib)

Completed
Has Results
  • Multiple Myeloma
  • Fountain Valley, California
  • +274 more
Jan 13, 2023

Multiple Myeloma Trial in Athens (Cevostamab, XmAb24306, Tocilizumab)

Recruiting
  • Multiple Myeloma
  • Athens, Greece
  • +1 more
Jan 2, 2023

Waldenstrom Macroglobulinemia, Multiple Myeloma, Chronic Lymphocytic Leukemia Trial in Worldwide (Iopofosine I 131 single dose,

Recruiting
  • Waldenstrom Macroglobulinemia
  • +8 more
  • Iopofosine I 131 single dose
  • +2 more
  • Redlands, California
  • +42 more
Dec 30, 2022

Multiple Myeloma Trial in Worldwide (Carfilzomib 20 mg/m^2, Carfilzomib 70 mg/m^2, Dexamethasone 40 mg)

Active, not recruiting
  • Multiple Myeloma
  • Carfilzomib 20 mg/m^2
  • +4 more
  • Gilbert, Arizona
  • +107 more
Dec 20, 2022

Multiple Myeloma Trial in Worldwide (ACY-241, Pomalidomide, Dexamethasone)

Active, not recruiting
  • Multiple Myeloma
  • Tucson, Arizona
  • +24 more
Dec 15, 2022

Multiple Myeloma Trial in Worldwide (Belantamab mafodotin, Daratumumab, Bortezomib)

Active, not recruiting
  • Multiple Myeloma
  • Belantamab mafodotin
  • +3 more
  • Yuma, Arizona
  • +150 more
Dec 9, 2022

Carfilzomib Among Multiple Myeloma Patients in Europe

Completed
  • Multiple Myeloma
    • Braunau, Austria
    • +114 more
    Dec 8, 2022

    Multiple Myeloma Trial in Worldwide (Pomalidomide, Bortezomib, Dexamethasone)

    Completed
    • Multiple Myeloma
    • Mobile, Alabama
    • +278 more
    Dec 6, 2022

    Multiple Myeloma Trial in Spain (REGN5458, Daratumumab, Carfilzomib)

    Recruiting
    • Multiple Myeloma
    • Athens, Greece
    • +8 more
    Nov 30, 2022

    Multiple Myeloma Trial in Worldwide (Belantamab mafodotin)

    Recruiting
    • Multiple Myeloma
    • Belantamab mafodotin
    • New Port Richey, Florida
    • +94 more
    Nov 30, 2022

    Multiple Myeloma Trial in Worldwide (Carfilzomib, Dexamethasone)

    Completed
    Has Results
    • Multiple Myeloma
    • Scottsdale, Arizona
    • +139 more
    Sep 9, 2022

    Multiple Myeloma Trial in Worldwide (ACY-1215 (Ricolinostat) in combination with pomalidomide and dexamethasone)

    Active, not recruiting
    • Multiple Myeloma
    • ACY-1215 (Ricolinostat) in combination with pomalidomide and dexamethasone
    • Atlanta, Georgia
    • +25 more
    Aug 31, 2022

    Multiple Myeloma Trial in Worldwide (Dexamethasone, Daratumumab, Bortezomib)

    Recruiting
    • Multiple Myeloma
    • Orlando, Florida
    • +240 more
    Aug 18, 2022

    Multiple Myeloma Trial in Worldwide (Iberdomide)

    Recruiting
    • Multiple Myeloma
    • Nantes, France
    • +3 more
    Aug 16, 2022

    Multiple Myeloma Trial in Worldwide (Elranatamab, Daratumumab, Pomalidomide)

    Recruiting
    • Multiple Myeloma
    • Woolloongabba, Queensland, Australia
    • +117 more
    Aug 3, 2022

    Multiple Myeloma Trial in Worldwide (Selinexor, Elotuzumab, Pomalidomide)

    Recruiting
    • Multiple Myeloma
    • Tucson, Arizona
    • +67 more
    Jul 26, 2022

    Multiple Myeloma Trial in Worldwide (Carfilzomib Lenalidomide Dexamethasone, Isatuximab Carfilzomib Lenalidomide Dexamethasone)

    Active, not recruiting
    • Multiple Myeloma
    • Carfilzomib Lenalidomide Dexamethasone
    • Isatuximab Carfilzomib Lenalidomide Dexamethasone
    • Ostrava, Czechia
    • +6 more
    Jul 26, 2022

    Multiple Myeloma Trial in Greece, Korea, Republic of, United States (Belantamab mafodotin)

    Recruiting
    • Multiple Myeloma
    • Belantamab mafodotin
    • Tucson, Arizona
    • +21 more
    Jul 20, 2022